Euclises Pharmaceuticals, Inc. — Form D/A
Euclises Pharmaceuticals, Inc. of ST. LOUIS, MO, a company, filed a Form D amendment with the SEC on 2015-10-01. The offering totals $1.9M, of which $1.9M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-10-01
- Form: D/A
- Accession: 0001550350-15-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.9M
- Amount sold: $1.9M
- Investors: 9
- Date of first sale: 2013-12-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-209852
Issuer
- Name: Euclises Pharmaceuticals, Inc.
- CIK: 0001550350
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 4320 FOREST PARK AVENUE, SUITE 303, ST. LOUIS, MO, 63108
- Phone: (314) 604-2850
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Robert W Karr | Director | SAINT LOUIS, MO |
| Eduardo J Martinez | Director | Cambridge, MA |
| Rick A Ryan | Director | St. Louis, MO |
| Rajesh J Devraj | Executive Officer | St. Louis, MO |
| Robert W Karr | Executive Officer | SAINT LOUIS, MO |
| Robert A Beardsley | Director | Grand Rapids, MI |
| BOBBY W SANDAGE, JR. | Director | ST. LOUIS, MO |
| BOBBY W SANDAGE, JR. | Executive Officer | ST. LOUIS, MO |
| Charles A Bolten | Director | St. Louis, MO |
| John J Talley | Director | St. Louis, MO |
| Robert J Calcaterra | Director | St. Louis, MO |
| Rajesh J Devraj | Director | St. Louis, MO |
| Rick J Ryan | Director | St. Louis, MO |
| Randy H Weiss | Director | St. Louis, MO |
| Randy H Weiss | Executive Officer | St. Louis, MO |
Other filings by this issuer (4)
More